The PK/PD Study of A Single Subcutaneous Injection of SHR-1222 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

October 14, 2019

Study Completion Date

January 6, 2020

Conditions

Osteoporosis

Interventions

DRUG

SHR-1222

Pharmaceutical form: water injection Route of administration: subcutaneous

DRUG

Placebo

Pharmaceutical form: water injection Route of administration: subcutaneous

Trial Locations (1)

2nd Xiangya Hospital of Central South University, Changsha

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT03870100 - The PK/PD Study of A Single Subcutaneous Injection of SHR-1222 in Healthy Subjects | Biotech Hunter | Biotech Hunter